LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 10213 | 8988 | 1.1363 | 1.0384 | MN20160318_Q02 | K16 | |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 69.11 | 84.90 | 92 | 8988 | 0.0102 | 0.0120 | MN20160318_Q02 | F21 |
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 325 | 8988 | 0.0362 | 0.2209 | MN20160318_Q02 | I18 | |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 959 | 8988 | 0.1067 | 0.4340 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Alpelisib | 3.1623 | 69.11 | 84.90 | 7908 | 8988 | 0.8798 | 0.9623 | MN20160318_Q02 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 281 | 8988 | 0.0313 | 0.1948 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 202 | 8988 | 0.0225 | 0.1376 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 4374 | 8988 | 0.4867 | 0.7969 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 5871 | 8988 | 0.6532 | 0.8773 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 69.11 | 84.90 | 6864 | 8988 | 0.7637 | 0.9214 | MN20160318_Q02 | N06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 412 | 8988 | 0.0458 | 0.2647 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 3 | 8988 | 0.0003 | -0.3916 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 6985 | 8988 | 0.7772 | 0.9264 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 69.11 | 84.90 | 1106 | 8988 | 0.1231 | 0.4647 | MN20160318_Q02 | K19 |
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 9220 | 8988 | 1.0258 | 1.0076 | MN20160318_Q02 | C09 | |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 69.11 | 84.90 | 6685 | 8988 | 0.7438 | 0.9139 | MN20160318_Q02 | N06 |
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 9011 | 8988 | 1.0026 | 1.0008 | MN20160318_Q02 | C09 | |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 69.11 | 84.90 | 7843 | 8988 | 0.8726 | 0.9599 | MN20160318_Q02 | K19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 69.11 | 84.90 | 931 | 8988 | 0.1036 | 0.4277 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 8796 | 8988 | 0.9786 | 0.9936 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 6671 | 8988 | 0.7422 | 0.9133 | MN20160318_Q02 | I03 | |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 69.11 | 84.90 | 4745 | 8988 | 0.5279 | 0.8188 | MN20160318_Q02 | F11 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.31623 | 69.11 | 84.90 | 8617 | 8988 | 0.9587 | 0.9875 | MN20160318_Q02 | M21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.11 | 84.90 | 8423 | 8988 | 0.9371 | 0.9808 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | 0 | 69.11 | 84.90 | 9400 | 8988 | 1.0458 | 1.0134 | MN20160318_Q02 | H10 |